Brief: Biosergen Q2 EBITDA SEK -11.039 Thousand
20/08/2025 07:31
Aug 20 (Reuters) - Biosergen Q2 adjusted EBIT SEK -11.039 thousand. Q2 EPS SEK -0.05 Q2 net income SEK -11.039 thousand
Recent news on Biosergen AB
See all newsBrief: Nasdaq Approves Biosergen's Delisting Application
Brief: Biosergen Applies For Delisting Of The Company's Shares From Nasdaq First North Growth Market Conditional Upon Completion Of The Merger With Flerie
Brief: Biosergen Resolves On Set-Off Issue
Brief: Biosergen Rights Issue Oversubscribed
Brief: Biosergen Reports H1 EBITDA Of SEK -10.5 Million